Company Filing History:
Years Active: 2004-2008
Title: Ulrich Buehmann: Innovator in Pharmaceutical Chemistry
Introduction
Ulrich Buehmann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target hormonal pathways.
Latest Patents
Buehmann holds 2 patents related to quinoline, isoquinoline, and phthalazine derivatives. His latest patents focus on these derivatives as antagonists of the gonadotropin-releasing hormone. This invention aims to provide new therapeutic options for conditions influenced by this hormone.
Career Highlights
Ulrich Buehmann is currently associated with Zentaris AG, a company known for its innovative approaches in the pharmaceutical industry. His work has been instrumental in advancing the understanding and application of hormonal antagonists in medical treatments.
Collaborations
Throughout his career, Buehmann has collaborated with esteemed colleagues such as Peter Strehlke and Peter Droescher. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Ulrich Buehmann's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the field. His work continues to influence the development of new therapeutic agents.